Maria Pilar
Maria Pilar Bañados Ortiz, San Fernando CL
Patent application number | Description | Published |
---|---|---|
20140041087 | BLACKBERRY PLANT NAMED 'EMILIA' - A new and distinct cultivar of Blackberry plant named ‘Emilia’ as described and shown herein. Distinctive characteristics of ‘Emilia’ include its earliness, thornless stems, large sized fruit and sweetness without bitter aftertaste. | 02-06-2014 |
20140196182 | Blackberry plant named 'Camila' - A new and distinct primocane-fruiting cultivar of Blackberry plant named “Camila” as described and shown herein. Distinctive characteristics of “Camila” include its earliness, thornless stems, large sized fruit and sweetness without bitter aftertaste. | 07-10-2014 |
20140373228 | Blackberry plant named 'Amara' - A new and distinct cultivar of Blackberry plant named ‘Amara’ as described and shown herein. ‘Amara’ has a primocane fruiting habit on a thornless plant, coupled with high fruit quality (visually attractive with excellent flavor, firmness, and low regression to red drupelets in post harvest). | 12-18-2014 |
Maria Pilar Civeira Murillo, Pamplona(navarra) ES
Patent application number | Description | Published |
---|---|---|
20090130055 | Use of a Cytokine From the Interleukin-6 Family In the Preparation of a Composition For Combined Administration With Interferon-Alpha - The invention relates to the use of at least one cytokine from the IL-6 family −gp130, preferably selected from among IL-11, the leukaemia inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin-1, ciliary neurotrophic factor (CNTF), the cardiotrophin-like cytokine (CLC) and combinations thereof or a DNA sequence encoding same, in the preparation of a pharmaceutical composition which is intended for combined administration with at least one IFN-α or a DNA sequence encoding same, for use in the treatment of viral diseases. The invention also relates to a pharmaceutical composition comprising a pharmaceutically-acceptable quantity of at least one cytokin from the IL-6 family −gp130 or a DNA sequence encoding same and a pharmaceutically-acceptable quantity of at least one IFN-α or a DNA sequence encoding same, a pharmaceutical kit and a method for the treatment of viral diseases with the combined administration of the aforementioned cytokines and IFN-α. | 05-21-2009 |
Maria Pilar De Frutos Escrig, Madrid ES
Patent application number | Description | Published |
---|---|---|
20110121228 | REVALUATION OF AQUEOUS WASTE STREAMS IN THE PROPYLENE OXIDE/STYRENE CO-PRODUCTION PROCESS - The present disclosure describes a method for the revaluation of aqueous waste streams generated in the propylene oxide and styrene co-production processes. In particular, it discloses a method of reducing the organic contaminant load from a highly contaminated aqueous stream and recovery from said stream of organic compounds that may be recirculated or used as fuel in the co-generation of energy, and which comprises: acidification of said aqueous stream with inorganic acid at a pH less than 4.5; separation of the two resulting phases at a temperature greater than 40° C.; washing of the organic phase produced in the previous step with an aqueous solution of excess acid and separation of the two resulting phases. | 05-26-2011 |
Maria Pilar Delgado Martinez, Sant Joan Despi ES
Patent application number | Description | Published |
---|---|---|
20130236450 | Methods Using Lipoprotein-Associated Phospholipase A2 in an Acute Care Setting - This invention relates to methods for using Lipoprotein-associated Phospholipase A2 (Lp-PLA2) to care for subjects in an acute care setting. Specifically, Lp-PLA2 can be used determine if a subject having a vascular event, such as a stroke or heart attack, will benefit from therapy in the acute care setting. Moreover, it relates to methods of assessing risk and severity of a stroke by evaluating Lp-PLA2 levels alone or in combination with other assessments. In addition the invention relates to methods of using Lp-PLA2 to assess the functional outcome in a subject having a vascular event such as a stroke or heart attack. | 09-12-2013 |
Maria Pilar Garcia-Pareja, Alhendin (granada) ES
Patent application number | Description | Published |
---|---|---|
20090018194 | Use of antimicrobial agents derived from alliaceous plants for the prevention and control of crop diseases, post-harvest rot and as environmental disinifectant products - The present invention is directed to utilization of antimicrobial agents derived from plants of the alliaceae family for the prevention and control of crop diseases, post-harvest rotting and as environmental disinfection products. The agents include propyl propylthiosulfinate and propyl propylthiosulfonate compounds for pre- and post-harvest treatments, control of rotting in fruits and vegetables; disinfection of agricultural soils, control of microorganisms, environmental disinfection in agricultural processing industries, facilities and equipment, disinfection of food containers and boxes. The agents can be used as pure active principles or in mixtures, in aqueous solutions or in any formulation, either liquid or supported in a solid agent or formulation; as single active principles or in formulation, together with other synthetic or natural antifungal agents, biocontrol agents, fertilizers, antioxidants, growth regulators or regulators of any other type; by means of immersion, fogging, wetting, spraying, atomization, injection in the soil, in irrigation systems, by means of drenchers or in general any other treatment or application system. | 01-15-2009 |
Maria Pilar Gimeno Tolosa, Zaragoza ES
Patent application number | Description | Published |
---|---|---|
20110160507 | METHOD FOR OBTAINING AROMATIC HYDROCARBONS FROM METHANE - Process for obtaining aromatic hydrocarbons from a stream containing at least one light hydrocarbon selected from the list comprising methane, ethane, ethylene, propane, propene, propylene, butane, butene or butadiene, which comprises putting said stream into contact with a catalyst, which comprises a catalytic material and a binder, in a fluidized bed reactor. Said reactor may have two reaction zones, an oxidizing zone and a reducing zone. | 06-30-2011 |
20110184191 | TWO-ZONE FLUIDISED-BED REACTOR | 07-28-2011 |
Maria Pilar González López, Madrid ES
Patent application number | Description | Published |
---|---|---|
20110270807 | Method In A Database Server - Method, apparatus and computer program for storing by a database server a plurality of data entries containing data related to a plurality of applications. The database server receives a request to modify the content of a data entry and checks a validation rule related to the entry before performing the modification. The validation rule contains information usable for determining valid data contents that can be stored in said entry, and information for building the validation rule is received from one or more application servers serving said applications. When a back end database server system stores data related to a plurality of applications, data validation check mechanisms are simplified, as information for performing validity checks are received from the application servers in the database system. | 11-03-2011 |
Maria Pilar Leret Molto, Madrid ES
Patent application number | Description | Published |
---|---|---|
20140336318 | METHOD FOR OBTAINING HIERARCHICALLY ORDERED INORGANIC PHOSPHATE STRUCTURES ON PHYLLOSILICATES - The present invention relates to a method for preparing hierarchically ordered structures of inorganic phosphate particles, homogeneously deposited on the surface of a phyllosilicate, which is characterized in that it comprises the following steps: a) obtaining an acid solution of precursor compounds of an inorganic phosphate; b) preparing a dispersion of particles of a phyllosilicate in aqueous medium and acidifying the phyllosilicate dispersion by adding at least one acid, thereby obtaining an acid dispersion; c) mixing the acid solution obtained in step a) with the dispersion obtained in step b); and d), with stirring, adding a base to the mixture obtained in step c) until the required pH value for precipitating the corresponding inorganic phosphate on the phyllosilicate particles has been achieved, resulting in a hierarchically ordered structure of homogeneously distributed submicrometric or nanometric inorganic phosphate particles supported on the phyllosilicate surface. | 11-13-2014 |
Maria Pilar Lopez Deber, Ecublens CH
Patent application number | Description | Published |
---|---|---|
20100144793 | NOVEL COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS - The present invention relates to compounds of the general formula (I) wherein (formula 2) independently represents a single bond or a double bond, represents a linking group A and A′ are each independently a 5- to 7-membered heterocyclic ring, wherein the heterocyclic rings A und A′ are optionally substituted by one or more substituents, selected from C | 06-10-2010 |
20100183513 | N-(METHYL) -1H-PYRAZOL-3-AMINE, N-(METHYL)-PYRIDIN-2-AMINE AND N-(METHYL)-THIAZOL-2-AMINE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS, LIKE E.G. ALZHEIMER'S - The present invention relates to novel compounds of formula (II) that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating, or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed. | 07-22-2010 |
20120309791 | NOVEL COMPOUND FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS - The present invention relates to novel compounds of formula (II) that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating, or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed | 12-06-2012 |
Maria Pilar Lopez-Deber, Lausanne CH
Patent application number | Description | Published |
---|---|---|
20130273149 | DISACCHARIDE SYNTHETIC LIPID COMPOUNDS AND USES THEREOF - Essentially pure compounds of the formulas (I) to (XX) are provided. Compositions and methods for enhancing or stimulating an immune response are also provided. The compounds, provided are advantageous in that the compounds are essentially pure and free from contaminants encountered when such compounds are purified from natural sources. | 10-17-2013 |
20130287838 | VACCINE ENGINEERING - The method and constructs disclosed and claimed herein allow to control peptide conformation by modulation of the peptide lipidation pattern, spacer and liposome composition, or via co-administration with small molecules. Accordingly, this technology can be applied to the rational design of liposomal vaccines and for the generation of safer and more efficacious therapies for a range of human disease, in particular those based on misfolded proteins. | 10-31-2013 |
20150110854 | Disaccharide Synthetic Lipid Compounds and Uses Thereof - Essentially pure compounds of the formulas (I) to (XXV) are provided. Compositions and methods for enhancing or stimulating an immune response are also provided. The compounds, provided are advantageous in that the compounds are essentially pure and free from contaminants encountered when such compounds are purified from natural sources. | 04-23-2015 |
Maria Pilar Marco Colas, Madrid ES
Patent application number | Description | Published |
---|---|---|
20160033489 | Haptenes and Conjugates Derived from Pyocyanin, Antibodies Thereof, and Immunichemical Method for Detecting Infections Caused by Pseudomonas Aeruginosa - The present invention relates to a compound of general formula I and to the use thereof as a hapten. | 02-04-2016 |
Maria Pilar Mateo Herrero, Valencia ES
Patent application number | Description | Published |
---|---|---|
20130273129 | INSECTICIDE AND ACARICIDE PAINTS THAT INHIBIT CHITIN SYNTHESIS, REGULATE INSECT JUVENILE HORMONE AND REPEL ARTHROPODS, FOR CONTROLLING ENDEMIC DISEASES, PESTS AND ALLERGENS - The present invention relates to insecticide and acaricide paints that inhibit chitin synthesis, regulate insect juvenile hormone and repel arthropods, for controlling endemic diseases, pests and allergens. The paints comprise at least the following compounds (in any combination): 1%-100% water, 0.0001%-20% insecticides, 0.0001%-20% chitin inhibitor, 0.0001%-20% juvenile hormone regulator, 1%-50% polymers, 0%-40% pigments, 0%-60% fillers, 0%-60% natural repellents, and 0.01%-20% stabilizers. The composition of the paints allows the active ingredients to be encapsulated in an aqueous polymer with or without the incorporation of fillers and pigments, and therefore the range of use thereof is increased. | 10-17-2013 |
Maria Pilar Munoz Lopez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20080265093 | Integrated multispar torsion box of composite material - The invention relates to an integrated multispar torsion box structure of composite material for aircraft, comprising a lower skin ( | 10-30-2008 |
20090001218 | Stifffened multispar torsion box - The invention relates to an integrated structure of a composite material multispar torsion box ( | 01-01-2009 |
Maria Pilar Perez De Obanos Martell, Pamplona ES
Patent application number | Description | Published |
---|---|---|
20140170125 | USE OF CARDIOTROPHIN-1 FOR THE TREATMENT OF KIDNEY DISEASES - The present invention relates to the use of cardiotrophin-1 (CT-1) for the prevention and/or treatment of acute renal injury, specially of acute kidney injury induced by nephrotoxic agents, such as contrast agents, antibiotics, immunosuppressive agents or antineoplastic agents. The invention is also related to compositions comprising said nephrotoxic agents and cardiotrophin-1. | 06-19-2014 |
Maria Pilar Pizcueta Lalanza, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20110129445 | COMBINATIONS COMPRISING METHOTREXATE AND DHODH INHIBITORS - The present disclosure relates to combinations comprising (a) methotrexate, and (b) a DHODH inhibitor and their uses. | 06-02-2011 |
20110280831 | COMBINATIONS COMPRISING METHOTREXATE AND DHODH INHIBITORS - The present invention provides a combination which comprises (a) methotrexate and (b) a non-hepatotoxic DHODH inhibitor of formula (I): wherein: R | 11-17-2011 |
Maria Pilar Rodriguez Molto, Ciudad De La Habana CU
Patent application number | Description | Published |
---|---|---|
20090304633 | CHIMERIC VACCINE ANTIGENS AGAINST CLASSICAL SWINE FEVER VIRUS - The current invention describes chimeric vaccine antigens against the virus that causes the Classic Swine Fever (CSFV). Such vaccine antigens are based on viral subunits coupled to proteins able to stimulate cellular and humoral immune system. Chimeric antigens can be produced in expression systems that guarantee a correct tertiary structure folding of the chimeric molecules, which constitute the essence of the current invention. The vaccine formulations containing such chimeric antigens induce an early and potent immune response on vaccinated pigs and confer full protection against CSFV. Moreover, the resultant vaccine formulations prevent the viral transmission from sows to their offspring. The chimeric antigens, as well as the resultant vaccine formulations, can be applied in animal health as vaccines for preventive use in swine. | 12-10-2009 |
20090324644 | CHIMERIC VACCINE ANTIGENS AGAINST THE AVIAN INFLUENZA VIRUS - The present invention describes chimeric vaccine antigens against the avian influenza virus (AIV). Said vaccine antigens are based on viral subunits that are coupled to protein molecules that stimulate not only the cellular but also the humoral immune system. The chimeric antigens may be produced in expression systems that guarantee correct three-dimensional folding of the chimeric molecules that constitute the basis of the present invention. The vaccine compositions that contain said chimeric antigens induce a potent, early immune response both in birds and in vaccinated mammals, stimulating high haemagglutinin-inhibiting antibody titres and a potent specific cellular response against the viral antigen. The chimeric antigens, and also the resulting vaccine compositions, are applicable to the field of human and animal health as vaccines for preventive use. | 12-31-2009 |
Maria Pilar Saenz Jimenez, Derio ES
Patent application number | Description | Published |
---|---|---|
20080274968 | IN VITRO METHODS FOR DETECTING RENAL CANCER - The present invention refers to an in vitro method for detecting the presence of renal cancer in an individual, for determining the stage, malignancy or severity of said carcinoma in the individual or for monitoring the effect of the therapy administered to an individual having said cancer; to the search, identification, development and assessment of the efficacy of compounds for therapy for said cancer in an attempt to develop new drugs; as well as to agents inducing Plexin-131 protein expression and/or activity, or to agents inhibiting the effects of Plexin-B1 protein expression and/or activity repression. | 11-06-2008 |
20110098191 | IN VITRO METHODS FOR DETECTING RENAL CANCER - The present invention refers to an in vitro method for detecting the presence of renal cancer in an individual, for determining the stage, malignancy or severity of said carcinoma in the individual or for monitoring the effect of the therapy administered to an individual having said cancer; to the search, identification, development and assessment of the efficacy of compounds for therapy for said cancer in an attempt to develop new drugs; as well as to agents inducing Plexin-131 protein expression and/or activity, or to agents inhibiting the effects of Plexin-B1 protein expression and/or activity repression. | 04-28-2011 |
Maria Pilar Villanueva Redon, Valencia ES
Patent application number | Description | Published |
---|---|---|
20110288224 | Polymeric Matrix Nanocomposite Materials Having Improved Mechanical and Barrier Properties and Procedure For Preparing Same - The present invention relates to nanocomposite materials based on a polymeric or plastic matrix and a laminar silicate (clay) having improved mechanical, thermal and gas-barrier properties, among others, and not requiring clay-matrix compatibilising agents. Furthermore the present invention relates to three procedures for the obtainment of these materials and use thereof for applications such as in packaging products of interest to the food sector, among others, and for applications in other sectors. | 11-24-2011 |
Maria Pilar Zaragoza Fernández, Zaragoza ES
Patent application number | Description | Published |
---|---|---|
20100261656 | Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin - The present invention relates to the therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin and of the polypeptide encoded by said sequence, preferably for the treatment of amyotrophic lateral sclerosis (ALS). | 10-14-2010 |
Maria Pilar Zaragoza Fernández, Zaragoza ES
Patent application number | Description | Published |
---|---|---|
20100261656 | Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin - The present invention relates to the therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin and of the polypeptide encoded by said sequence, preferably for the treatment of amyotrophic lateral sclerosis (ALS). | 10-14-2010 |
María Pilar Aranda Gallego, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130062286 | METHOD FOR OBTAINING MATERIALS WITH SUPERPARAMAGNETIC PROPERTIES - The present invention relates to a method for obtaining materials based on treating solids by interaction with ferrofluids to give the final product a superparamagnetic behaviour at a moderate temperature. Said superparamagnetic materials are the result of the assembly of metal oxide nanoparticles associated to a compound with a surfactant effect, such as oleic acid, which are provided by a non-aqueous ferrofluid to different types of solids, preferably having adsorbent, absorbent or reactant and product support properties. The invention also relates to the material obtained by this procedure and its use in various applications such as adsorbents, sensors, ion exchangers the removal of toxic or radioactive contaminants, in chromatographic separation processes, in medical and biological applications, as carriers of biologically derived materials such as enzymes, as polymer fillers, absorption of electromagnetic radiation, as well as metal oxide and catalyst precursors. | 03-14-2013 |
María Pilar Aranda Gallego, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130062286 | METHOD FOR OBTAINING MATERIALS WITH SUPERPARAMAGNETIC PROPERTIES - The present invention relates to a method for obtaining materials based on treating solids by interaction with ferrofluids to give the final product a superparamagnetic behaviour at a moderate temperature. Said superparamagnetic materials are the result of the assembly of metal oxide nanoparticles associated to a compound with a surfactant effect, such as oleic acid, which are provided by a non-aqueous ferrofluid to different types of solids, preferably having adsorbent, absorbent or reactant and product support properties. The invention also relates to the material obtained by this procedure and its use in various applications such as adsorbents, sensors, ion exchangers the removal of toxic or radioactive contaminants, in chromatographic separation processes, in medical and biological applications, as carriers of biologically derived materials such as enzymes, as polymer fillers, absorption of electromagnetic radiation, as well as metal oxide and catalyst precursors. | 03-14-2013 |
María Pilar Civeira Murillo, Pamplona (navarra) ES
Patent application number | Description | Published |
---|---|---|
20110027224 | USE OF A CYTOKINE FROM THE INTERLEUKIN-6 FAMILY IN THE PREPARATION OF A COMPOSITION FOR COMBINED ADMINISTRATION WITH INTERFERON-ALPHA - The invention relates to the use of at least one cytokine from the IL-6 family −gp130, preferably selected from among IL-11, the leukaemia inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin-1, ciliary neurotrophic factor (CNTF), the cardiotrophin-like cytokine (CLC) and combinations thereof or a DNA sequence encoding same, in the preparation of a pharmaceutical composition which is intended for combined administration with at least one IFN-α or a DNA sequence encoding same, for use in the treatment of viral diseases. The invention also relates to a pharmaceutical composition comprising a pharmaceutically-acceptable quantity of at least one cytokin from the IL-6 family −gp130 or a DNA sequence encoding same and a pharmaceutically-acceptable quantity of at least one IFN-α or a DNA sequence encoding same, a pharmaceutical kit and a method for the treatment of viral diseases with the combined administration of the aforementioned cytokines and IFN-α. | 02-03-2011 |
María Pilar Civeira Murillo, Pamplona (navarra) ES
Patent application number | Description | Published |
---|---|---|
20110027224 | USE OF A CYTOKINE FROM THE INTERLEUKIN-6 FAMILY IN THE PREPARATION OF A COMPOSITION FOR COMBINED ADMINISTRATION WITH INTERFERON-ALPHA - The invention relates to the use of at least one cytokine from the IL-6 family −gp130, preferably selected from among IL-11, the leukaemia inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin-1, ciliary neurotrophic factor (CNTF), the cardiotrophin-like cytokine (CLC) and combinations thereof or a DNA sequence encoding same, in the preparation of a pharmaceutical composition which is intended for combined administration with at least one IFN-α or a DNA sequence encoding same, for use in the treatment of viral diseases. The invention also relates to a pharmaceutical composition comprising a pharmaceutically-acceptable quantity of at least one cytokin from the IL-6 family −gp130 or a DNA sequence encoding same and a pharmaceutically-acceptable quantity of at least one IFN-α or a DNA sequence encoding same, a pharmaceutical kit and a method for the treatment of viral diseases with the combined administration of the aforementioned cytokines and IFN-α. | 02-03-2011 |
María Pilar Goya-Laza, Madrid ES
Patent application number | Description | Published |
---|---|---|
20090221710 | Acyclic Sulfamide Derivatives - The present invention is related to acyclic sulfamide derivatives, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulfamide derivatives are also useful for cosmetic use. | 09-03-2009 |
20100004224 | 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS - The invention relates to the use of compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,4-triazole derivatives of formula (I) to processes of preparation of such compounds and to pharmaceutical compositions comprising them. | 01-07-2010 |
20100004265 | 1,2,3-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS - The invention relates to compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,3-triazole derivatives of formula (I) and to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and prophylaxis, in particular for the treatment of psychosis or pain. | 01-07-2010 |
20100048712 | Acyclic Sulfamide Derivatives - The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R | 02-25-2010 |
20100179224 | Acyclic Sulfamide Derivatives - The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R | 07-15-2010 |
20120004211 | 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS - The invention relates to the use of compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,4-triazole derivatives of formula I | 01-05-2012 |
María Pilar Goya-Laza, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100048712 | Acyclic Sulfamide Derivatives - The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R | 02-25-2010 |
20100179224 | Acyclic Sulfamide Derivatives - The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R | 07-15-2010 |
María Pilar Marco Colas, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100193378 | IMPEDIMETRIC SENSOR AND APPLICATIONS THEREOF - The invention relates to a highly sensitive impedimetric sensor in which the highly conductive electrodes are separated by a barrier of insulating material. Said sensor is used to determine directly the presence of analytes in a biological sample of human, veterinary or environmental origin. | 08-05-2010 |
20120309108 | MULTI-ANALYTE SYSTEM AND METHOD BASED ON IMPEDIMETRIC MEASUREMENTS - The invention discloses a system for the simultaneous detection and/or quantification of various analytes in a sample or for the simultaneous detection and/or quantification of an analyte in various samples, comprising: a multi-electrode chip ( | 12-06-2012 |
20130273581 | HAPTENS AND IMMUNOREACTIVE AGENTS AND USE THEREOF FOR PRODUCING FAMILY ANTIBODIES AND IMMUNOASSAYS FOR QUINOLONES - The invention relates to haptens, immunogens and secondary immunoreactive agents, to the use thereof for producing wide-spectrum antibodies against quinolone-type antibiotics, to the application thereof to immunochemical analysis techniques, and to a kit enabling the detection of said antibiotics in biological samples from food products of animal origin. | 10-17-2013 |
María Pilar Marco Colas, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100193378 | IMPEDIMETRIC SENSOR AND APPLICATIONS THEREOF - The invention relates to a highly sensitive impedimetric sensor in which the highly conductive electrodes are separated by a barrier of insulating material. Said sensor is used to determine directly the presence of analytes in a biological sample of human, veterinary or environmental origin. | 08-05-2010 |
20120309108 | MULTI-ANALYTE SYSTEM AND METHOD BASED ON IMPEDIMETRIC MEASUREMENTS - The invention discloses a system for the simultaneous detection and/or quantification of various analytes in a sample or for the simultaneous detection and/or quantification of an analyte in various samples, comprising: a multi-electrode chip ( | 12-06-2012 |
María Pilar MuÑoz LÓpez, Cuenca ES
Patent application number | Description | Published |
---|---|---|
20120305707 | COMPOSITE AIRCRAFT FRAME - Composite aircraft frame ( | 12-06-2012 |
María Pilar MuÑoz LÓpez, Cuenca ES
Patent application number | Description | Published |
---|---|---|
20120305707 | COMPOSITE AIRCRAFT FRAME - Composite aircraft frame ( | 12-06-2012 |